[[Dacetuzumab]]

CATEGORIES: Monoclonal antibodies for tumors

Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibodyStatement On A Nonproprietary Name Adopted By The USAN Council - Dacetuzumab, American Medical Association. being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma[tpl]pmid|19636010[/tpl] and hematological malignancies.[tpl]pmid|19513947[/tpl]
This drug was developed by Seattle Genetics, Inc.

==References==


